MTRC has released an introductory seminar on market access for in-vitro diagnostic tests

06

Sep 2019

Market access is a complex discipline that includes topics of reimbursement, funding, health technology assessment, clinical epidemiology, and stakeholder engagement.

At the moment, there is no good introductory training in market access for in-vitro diagnostic tests in Europe. Market access professionals develop an understanding of the disciple through work experience and conferences.

MTRC has bridged the gap with a seminar, aimed to give a brief, but comprehensive understanding of core concepts in the field of market access for IVD tests in Europe.

The seminar includes overview of topics of reimbursement, funding, payment mechanisms for IVD tests in hospital, day case and out-patient settings, health technology assessment, innovation funding, the role of clinical and economic evidence, stakeholder engagement.

The seminar includes general concepts of market access as well as some specifics of the market access situation in 10 EU countries (Austria, Belgium, England, France, Germany, Italy, Netherlands, Norway, Sweden and Switzerland).

The seminar is available as a pre-recorded on-demand webinar or full presentation in Acrobat PDF.

Learn more and request a quote here

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more